Fintel reports that on October 29, 2026, Jefferies downgraded their outlook for Boston Scientific (NYSE:BSX) (BMV:BSX) from Buy to Hold. This rating action follows a prior action by Jefferies on June ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2026-10-31 01:02:22









